HALBERT JON

SEC Form 4 insider trading activity

HALBERT JON has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.

On the most recent filing, HALBERT JON is listed as Director at Caris Life Sciences, Inc. Inside the rolling window, HALBERT JON reported 1 open-market purchase totaling $990K in CAI and no open-market sales.

Companies traded

Other insiders at CAI

Insider Buying

$990K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CAI
HALBERT JON
Purchase$990KJul 13SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has HALBERT JON made?

HALBERT JON has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.

Which companies does HALBERT JON trade?

HALBERT JON has filed SEC Form 4 disclosures for 1 company, including CAI.

When was HALBERT JON's most recent SEC Form 4 filing?

HALBERT JON's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.

What is HALBERT JON's total buy and sell value in the current window?

Inside the rolling retention window, HALBERT JON bought $990K and sold $0 based on SEC Form 4 filings.

What was HALBERT JON's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 68,000 CAI shares on 2026-05-15, worth $990K, per SEC Form 4 filings.